HOME
ABOUT
LOG-IN
SEARCH BY
Search Results
Search Terms:Company Category= Life Sciences Company-Biotech| Adesis, Inc. 27 McCullough Drive New Castle, DE 19720 302-323-4880 Susan Baylis-Powell sbaylis-powell@adesisinc.com www.adesisinc.com Adesis is a contract research organization (CRO) supporting the pharmaceutical and biopharmaceutical industry. This industry is adopting the philosophy of outsourcing reference standards (competitor’s drugs), targets, scaffolds, building blocks and advanced intermediates. Outsourcing allows medicinal chemists to focus on design and assembly of new targets for pharmacological evaluation and streamlines the early stage drug discovery process. |
| Adolor Corporation 700 Pennsylvania Drive Exton, PA 19341 484-595-1500 Lizanne Wentz questions@adolor.com www.adolor.com Adolor Corporation (Nasdaq: ADLR) is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. By applying its knowledge and expertise in pain management, along with ingenuity, Adolor is seeking to make a positive difference for patients, caregivers and the medical community. |
| Aptagen, LLC 250 North Main Street Jacobus, PA 17407 717-278-2436 G. Thomas Caltagirone, Ph.D. mailbox@aptagen.com www.aptagen.com Aptagen, LLC is a biotechnology company offering aptamer and aptabody custom-based services to replace antibodies in research, diagnostic platforms, drug discovery and therapeutics. |
| Athena Biotechnologies, Inc. Stine-Haskell Research Center 1090 Elkton Road Newark, DE 19711 302-224-3450 Barry L. Marrs, CTO bmarrs@athenabio.com www.athenabio.com Athena Biotechnologies, Inc. is a privately-held, early-stage biotechnology company. AthenaBio is focused on harvesting bioactive molecules from nature. We are committed to delivering these novel chemicals and enzymes to fill critical unmet needs in pharmaceuticals, agrichemicals, and industrial and therapeutic enzymes markets. |
| Augmenta Biologicals, LLC 1000 N. West St., Suite 1200 Wilmington, DE 19801 302-764-2043 Paul Simon simonpm@augmentabio.com www.augmentabio.com Augmenta is developing an enabling technology to increase the potency of immunogens used to immunize animals for antibody production and also for use in veterinary and human vaccines, without the use of conventional immune adjuvants. |
| Auxilium Pharmaceuticals 40 Valley Stream Parkway Malvern, PA 19355 484-321-5900 MaryLou McGurk mlmcgurk@auxilium.com www.auxilium.com Auxilium Pharmaceuticals (NASDAQ: AUXL) was founded in 1999 to develop and market pharmaceutical products that focus on urology and sexual health. While we remain dedicated to this founding principle, Auxilium’s mission has expanded to include the development and marketing of novel treatment options for many of society’s unmet medical needs. |
| Avid Radiopharmaceuticals 3624 Market Street 5th Floor Philadelphia, PA 19104 215-966-6208 Nan Kruzik kruzik@avidrp.com www.avidrp.com Avid Radiopharmaceuticals is a product-focused molecular imaging company. Avid has developed proprietary radiopharmaceuticals to image amyloid plaques and is testing these agents in clinical trials for the detection of Alzheimer’s. Avid is also developing novel agents to image pathology in other types of dementia and Parkinson’s. These agents have the potential to revolutionize early diagnosis and monitoring of neurodegenerative diseases. |
| B-Tech Consulting, Ltd. 3701 Market Street 5th Floor Suite 119 Philadelphia, PA 19104 215-989-4880 Brian Moldover, Ph.D. brian@b-techconsulting.com www.b-techconsulting.com B-Tech Consulting, Ltd. provides Bio and Chemo Informatics contract research and analytical services to the Biotechnology and Pharmaceutical sectors. B-Tech Consulting, Ltd. Also provides Genomic data analysis, chemical library virtual screening, Next-Generation sequencing, expression profiling, SNP's, miRNA. |
| B. McLaughlin Associates, Inc. 1540 McDaniel Drive West Chester, PA 19380 610-430-1847 Kristen Molina Kristen@bmclaughlin.com http://www.bmclaughlin.com/ BMA is a niche provider of clinical research services based in West Chester, Pennsylvania and Phoenix, Arizona. Our services focus on Study Management, Regulatory and Financial Document Retrieval, Clinical Study Agreement/Per Patient Budget Negotiation, Informed Consent Review and Approval, Data Discrepancy Retrieval, and Regulatory Document Audits. |
| BioLeap, LLC 346A Lurgan Road New Hope, PA 18938-9252 215-371-2874 Gerry Evans information@bioleap.com www.bioleap.com Bioleap is a virtual drug discovery company focused on targets where opportunities exist to significantly improve drug performance with novel, SECOND GENERATION compounds. Development collaborations span a broad spectrum of target proteins including kinases, nuclear hormone receptors, metalloenzymes, and metalloproteases. The current focus of our internal programs is anti-bacterials. Novel compounds have been identified for peptide deformylase inhibitors. |
| Biomol International, LP 5120 Butler Pike Plymouth Meeting, PA 19462 800-942-0430 Jane Love marketing@biomol.com www.biomol.com BIOMOL, located in Plymouth Meeting, offers a wide range of biochemicals with applications in signal transduction, gene regulation, apoptosis, neuroscience, and drug discovery. In addition to purified enzymes, antibodies, and assay kits, BIOMOL’s innovative products include Nupherin-neuron transfection reagent, Fluor de Lys HDAC assay kit, and Screen-Well compound libraries. |
| Biosome, Inc. 701-4 Cornell Business Park Wilmington, DE 19801 302-654-4492 Charles F. Saller, Ph.D. csaller@absbio.com www.biosome.com Biosome, Inc. is founded upon an innovative fluorescent nanoparticle detection technology with applications in drug discovery and pathogen detection. Drug discovery products will predict if potential drugs will reach their target, while greatly reducing the costs of these evaluations and vastly increasing their throughput. Pathogen detection products are being developed for markets such as food and water safety and biodefense. |
| Capital Biosciences, Inc. 9700 Great Seneca Hwy Suite 247 Rockville, MD 20850 240-207-2314 Gary Veytsman techsupport@capitalbiosciences.com http://www.capitalbiosciences.com Capital Biosciences, Inc. offers innovative tools and solutions for life sciences researchers worldwide, including: fresh viable, frozen, and FFPE human tissues; cell immortalization products and services; and fluorescent in vivo imaging products. |
| Cartesian Software 535 Cedar Drive Lafayette Hill, PA 19444 610-940-4711 Thomas Rossi thom.rossi@cartesiansoftware.com www.cartesiansoftware.com Cartesian Software was founded to improve drug safety. The company’s product, Data Lens, helps users quickly identify safety questions and use clinical trial data more efficiently. |
| Cellular GenetiX 1600 Arch Street Suite 1211 Philadelphia, PA 19103 215-665-1193 Dr. David Targan David@cellulargenetix.com www.cellulargenetix.com Cellular GenetiX is a leading service industry provider offering various genetic and pharmacogenomic testing and functioning as a portal for patients to have access to entities involved in the highly anticipated growth sector of genomic therapies. |
| Ception Therapeutics, Inc. 101 Lindenwood Drive Suite 400 Malvern, PA 19355 610-640-2940 Janet Rivello contactus@ceptiontx.com www.ceptiontx.com Ception Therapeutics is an emerging biopharmaceutical company focused on the discovery and development of novel products to address unmet medical needs. Ception was founded by experienced pharmaceutical executives in order to develop and commercialize therapeutics in areas of significant unmet medical need. |
| Derma Sciences Inc. 214 Carnegie Center Suite 300 Princeton, NJ 08540 609-514-4744 Barry Wolfenson bwolfenson@dermasciences.com www.dermasciences.com Derma Sciences is a global manufacturer and marketer of advanced wound-care products. Its key product, MEDIHONEY™, is sold throughout the world. Derma has two products in development: the BIOGUARD™ line of barrier gauze dressings is pending its initial FDA marketing clearance; and DSC127, the company's novel angiotensin analog for accelerated wound healing and scar reduction is entering into a Phase II study. |
| Diasome Pharmaceuticals, LLC 625 Ridge Pike Building E, Suite 402 Conshohocken, PA 19428 609-923-9443 lrosenberg@diasome.com lrosenberg@diasome.com www.diasome.com Diasome Pharmaceuticals is dedicated to improving the lives of Type 1 and Type 2 Diabetes patients. Our patented nanotechnology targeted delivery systems have demonstrated preferential delivery of insulin to the liver. We have developed a proven process for advancing compounds from early stage through completion of Phase II studies faster than traditional methods at a fraction of the cost. |
| Discovery Laboratories, Inc. 2600 Kelly Road Suite 100 Warrington, PA 18976 215-488-9300 Lisa Caperelli lcaperelli@discoverylabs.com www.discoverylabs.com Discovery Labs is a biotechnology company developing its Surfactant Replacement Therapy to advance respiratory medicine and address a variety of respiratory diseases. Discovery’s technology produces a precision-engineered surfactant that is designed to mimic natural human lung surfactant. Surfaxin, Discovery’s most advanced product, has received an Approvable Letter from the US FDA for the prevention of RDS in premature infants. |
| Dynamis Therapeutics, Inc. 261 Old York Road Suite 427 Jenkintown, PA 19046 215-376-5290 Annette Tobia, JD, PhD ATobia@Dynamis-Therapeutics.com www.dynamis-therapeutics.com Dynamis Therapeutics was founded to capitalize on a breakthrough discovery by scientists at Fox Chase Cancer Center of a novel enzymatic pathway that leads to the production of a highly toxic sugar breakdown compound called 3-deoxyglucosone, or 3DG. Additional research confirmed that this 3DG pathway could be responsible for chronic inflammatory conditions ranging from skin wrinkling to severe diabetic complications such as retinopathy and nephropathy. |
| EKR Therapeutics, Inc. 7 East Frederick Place Cedar Knolls, NJ 07927 877-435-2524 NA postmaster@ekrtx.com www.ekrtx.com EKR Therapeutics is an emerging specialty pharmaceutical company that is focused on oncology supportive care and the commercialization of prescription products to fill unmet patient needs. |
| ElizaNor Polymer, LLC 1 Woodmeadow Lane Princeton Junction, NJ 08550-1323 609.799.2812 Dr. John Hartmann ElizaNor@aol.com ElizaNor Polymer, LLC, has developed a family of proprietary nanoparticles composed of chitosan, poly glutamic acid and hyaluronic acid(HA). The technology is flexible. Their size can be controlled (40 nm- several hundred nm) and morphology varied to suit a variety of applications. HA particle possesses remarkably low viscosity. Manufacture is in completely aqueous systems requiring no special conditions. |
| ERYtech Pharma 3701 Market Street, Suite 340 Philadelphia , PA 19104 215-966-6190 Orelie Cathaud orelie.cathaud@idis.fr http://erytech.com/ ERYtech specializes in the encapsulation of therapeutic molecules and enzymes in red blood cells. ERYtech have developed and patented an innovative technology of red blood cell encapsulation of molecules and enzymes -- a major breakthrough in the fields of cancer and enzyme therapy. It is now possible to mass produce processed erythrocytes while ensuring stability, reproductibility and constant quality, whatever their initial characteristics and origin. |
| Fraunhofer USA Center for Molecular Biotechnology 9 Innovation Way Suite 200 Newark, DE 19711 302-369-1708 Vidadi Yusibov personnel@fraunhofer-cmb.org www.fraunhofer-cmb.org The Fraunhofer Center for Molecular Biotechnology (FhCMB) is a not-for-profit, contract research organization, developing and applying plant science and other core platform technologies for the production of valuable proteins. We have special expertise in a platform technology known as transient gene expression, which provides excellent protein yields in a short time. |
| Frontage Laboratories, Inc. 105 Great Valley Parkway Malvern, PA 19355 610-232-0100 Ron Connolly rconnolly@frontagelab.com www.frontagelab.com Frontage Laboratories is a leading pharmaceutical development company delivering high-quality research services to support pharmaceutical discovery, development and commercialization for large and emerging companies. We assist our partners in resolving complex product development issues through our combined experience in pharmaceutical analysis, bioanalytical testing and method development, and custom synthesis of investigational compounds. Fully compliant with cGMP/GLP regulations, we offer quality services, rapid turnaround and competitive pricing. |
| Galleon Pharmaceuticals, Inc. Silver Lake Executive Campus 41 University Drive - Suite 400 Newtown, PA 18940 267-757-8755 Linda Souder info@galleonpharma.com www.galleonpharma.com Galleon is an early stage pharmaceutical company that is developing a new class of innovative medicines for use in a wide variety of medical specialties including pulmonology, neurology, cardiology, sleep medicine and pediatrics. |
| Genmab, Inc. 457 N. Harrison St. Princeton, NJ 08540 609-430-2481 Lucy McNiece lmb@us.genmab.com www.genmab.com Genmab is a biotechnology company that creates and develops human antibodies for the treatment of life-threatening and debilitating diseases. Genmab has numerous products in development to treat cancer, infectious disease, rheumatoid arthritis and other inflammatory conditions, and intends to continue assembling a broad portfolio of new therapeutic products. Genmab is an international company with operations in Europe and the United States. |
| GlaxoSmithKline Biopharmaceuticals 709 Swedeland Road UE4021 King of Prussia, PA 19406 610-239-3887 Anthony J Zuazo, CPA gsk.biopharm@gsk.com http://biopharm.gsk.com GSK Biopharmaceuticals is a full-service partner in the development and cGMP preparation of biopharmaceutical proteins for clinical trials and the marketplace. Our features services include the low-cost, rapid scale-up and manufacture of mammalian cell derived proteins at up to 5,000L scale and the preparation of formulated bulk products. |
| Immune Control, Inc. Four Tower Bridge 200 Barr Harbor Drive, Suite 450 West Conshohocken, PA 19428 610-941-2971 Peter Lutes plutes@immunecontrol.com www.immunecontrol.com Immune Control is founded on a novel observation—the neurotransmitter, serotonin, is essential for the replication of activated immune cells. When serotonin receptors on immune cells are blocked, the cells die. The Company is thus pursuing specific serotonin antagonists for use against lymphoproliferative cancers, autoimmune diseases, and transplant rejection. |
| Immunicon Corporation 3401 Masons Mill Road Suite 100 Huntingdon Valley, PA 19006 215-830-0777 Byron D. Hewett, President and CEO BHewett@Immunicon.com www.immunicon.com Immunicon is developing and commercializing diagnostic and research products for rare cell analysis and molecular research, with an initial focus on cancer. Our instruments and reagents are used to capture, count and characterize rare cells including circulating tumor cells in cancer patients or circulating endothelial cells, which are elevated in a variety of diseases. |
| Immunotope, Inc. The Pennsylvania Biotechnology Center 3805 Old Easton Road Doylestown, PA 19002 215-297-8493 Edward L. Erickson eerickson@immunotope.com www.immunotope.com Immunotope is a clinical-stage biotechnology company developing immunotherapy products for the treatment of cancer and viral infections. The Company’s lead product candidate is an immunotherapeutic vaccine for advanced stage ovarian and breast cancer. Also in development are immunotherapeutics for treatment and prevention of chronic hepatitis and HIV, and autoantibody-based tests for early-stage diagnosis of ovarian and prostate cancer. |
| Impact Biologicals, Inc. 520 Georgetown Road Wallingford, PA 19086 610-543-6320 Bernard Selling info@impactbio.com www.impactbio.com Impact Biologicals,. Inc produces recombinant proteins, cell lines and plasmids for biomedical research organizations. The company has expertise in mammalian, insect and bacterial expression systems and has purified proteins using a wide range of methods. ELISA and biochemical assays are also developed routinely. |
| InB:Biotechnologies, Inc. 9 Innovation Way Suite 100 Newark, DE 19711 302-355-0650 Jennifer Kmiec info@inb-biotechnologies.com www.inb-biotechnologies.com We are developing and commercializing a proprietary platform technology using non-genetically modified plants for the rapid production of a broad range of vaccines, therapeutic proteins and antibodies. Key advantages over conventional production systems include very large scale capacity with greatly reduced capital requirements. Our pipeline includes novel influenza, anthrax and plague vaccine candidates and therapeutic antibodies for anthrax and influenza. |
| Integral Molecular, Inc. 3701 Market St Philadelphia, PA 19104 215-966-6061 Benjamin Doranz info@integralmolecular.com www.integralmolecular.com Integral Molecular is a biotechnology company commercializing high-value platform technologies that aid drug discovery against integral membrane proteins, including GPCRs, ion channels, and viral Envelope proteins. |
| Inteprod LLC 970-200 Rittenhouse Road Eagleville, PA 19403 610-650-9002 Lori Pegon inteprodinfo@inteprod.com www.inteprod.com Inteprod is a full-service supplier of comprehensive design, development, contract manufacturing, and assembly services for the medical, food safety, and pathogen detection industries. Inteprod’s deep expertise and capabilities in developing and manufacturing medical and food safety products include: handheld devices; point of care diagnostics; bedside diagnostics; LOC technology; patient monitoring; analytical instruments; minimally invasive surgical instruments; and pathogen detection diagnostics. |
| Intrexon Corporation 2650 Eisenhower Avenue Norristown, PA 19403 610-650-8734 Shannon Hodous info@intrexon.com www.intrexon.com Intrexon Corporation is a biotechnology company focused on the research and development of gene-based therapeutics for use against challenging diseases. Our comprehensive technology platform delivers highly optimized gene programs that can be tightly regulated as to their on/off state, levels of expression, and genomic positioning. The company is currently engaged in specific therapeutic initiatives targeting melanoma, glioma, cardiac hypertrophy, and Parkinson's disease. |
| Kibow Biotech 4629 West Chester Pike Newtown Business Center Newtown Square, PA 19073 610-353-5130 Dr Rangan info@kibowbiotech.com www.kibowbiotech.com Philadelphia-based Kibow Biotech, Inc. produces cost-effective, scientifically validated products that prolong the life of kidney disease patients and also provide a better quality of life. A novel technology called “Enteric Dialysis” is used to remove uremic toxins in the bowel by probiotics. The company has also developed a range of clinically tested and scientifically formulated products to target metabolic syndrome. |
| Labrepco, Inc. 101 Witmer Road Suite 700 Horsham, PA 19044 800-521-0754 Vanessa Good sales@labrepco.com www.labrepco.com LABREPCO is a distributor of capital laboratory equipment and instrumentation to the life sciences research community., which includes the “traditional” pharmaceutical, biotechnology and government research venues as well as academic, forensic and industrial research laboratories. Our products represent a broad collection of laboratory appliances and instruments that we expertly dovetail with the specific needs of our customers. |
| Lampire Biological Laboratories, Inc. P.O. Box 270 Pipersville, PA 18947 215-795-2838 Gregory F. Krug lampire@lampire.com www.lampire.com LAMPIRE Biological Laboratories supplies antibodies, reagents, and raw materials to the pharmaceutical, diagnostic, and medical device industries, plus academic and government research institutions worldwide. Areas of expertise include antibody development, cell culture, control and reagent manufacturing, immunoassay development, veterinary sciences, and animal technology. Furthermore, LAMPIRE has earned primary vendor status with its clients through its commitment to Quality and Customer Service. |
| Lazarus Therapeutics, Inc. University City Science Center 3701 Market St., 3rd Floor Philadelphia, PA 19104 215-966-6051 Edward L. Erickson eerickson@sciencecenter.org Lazarus Therapeutics, Inc., (LTI) is a neurosciences company developing and commercializing novel therapeutic products for debilitating central nervous system (CNS) conditions, with Parkinson's disease as the initial target. The Company's strategy is to create value rapidly and reach the market through: (1) the "repurposing" and/or reformulation of existing, marketed drugs; and (2) development of "orphaned" or overlooked drug candidates for CNS indications. |
| LifeSensors, Inc. 271 Great Valley Parkway Malvern, PA 19355 610-644-8845 x 300 Joseph Ray info@lifesensors.com www.lifesensors.com LifeSensors is a biotechnology company located 35 miles west of Philadelphia. The company markets variety of proprietary SUMOpro® protein expression and purification technologies for difficult- to-express proteins and peptides. LifeSensors has also developed Functional Protein Arrays for diagnostics and drug discovery. The company has launched number of products for ubquitin pathway research and drug discovery. |
| Locus Pharmaceuticals, Inc. Four Valley Square 512 E. Township Line Road Blue Bell, PA 19422 215-358-2000 Robert Dickey IV communications@locuspharma.com www.locuspharma.com Locus is a world leader in computational drug design. Its core technology is a fragment-based, computational approach, which it has combined with highly integrated medicinal chemistry, crystallography and biology capabilities to create a unique drug-design and development platform. Locus develops its own compounds and has entered into drug design/development collaborations with pharmaceutical partners. Development programs are focused on oral drug therapies, principally in cancer and inflammation. |
| MicroDysis, Inc. 1200 Florence-Columbus Rd EcoComplex Suite 212 Bordentown, NJ 08505 6096421184 Joseph Z. Huang jhuang@microdysis.com www.microdysis.com MicroDysis, Inc. is a biotechnology instrumentation company that develops, manufactures, and markets biomedical devices and equipment based upon its patented micro- and nano-fabrication platform technologies. The goal is to commercialize its Fluidic nanoArray for highly efficient, highly sensitive, easily customized, and low-cost analysis of molecular biomarkers in earlier detection of cancer and personalized medicine applications. |
| Mobinol Fuel Company 119 Hunt Club Drive Collegeville, PA 19426 484-432-9007 John J. Savarese, Ph.D.,M.D. savarej@comcast.net www.MobinolFuel.com Mobinol Fuel Company provides the equipment and technology to convert cellulosic biomass into fuel ethanol on the farm or field. "Making Green Fuel Where Green Grows" is done with Ethanoil technology and Ethanol Mobile Bio-Reactor (EMBR)units. Turn crop waste into a cash crop while also reducing dependence on petroleum fuels. |
| Molecular Devices 402 Boot Road Downingtown, PA 19335 800-635-5577 Mike Duvinski Mike.Duvinski@moldev.com www.MolecularDevices.com Molecular Devices Corporation is a leading supplier of high-performance bioanalytical measurement systems that accelerate and improve drug discovery and other life sciences research. Our systems and consumables enable pharmaceutical and biotechnology companies to leverage advances in genomics, proteomics and parallel chemistry by facilitating the high-throughput and cost-effective identification and evaluation of drug candidates. |
| NanoScan Imaging, LLC 2250 Berks Road Lansdale, PA 19446 215-699-1703 Don Skerrett, CEO DSkerrett@aol.com www.nanoscanimaging.com NanoScan Imaging is managing the clinical development of N1177, a nanoparticle diagnostic pharmaceutical expected to improve x-ray computed tomography (“CT”)’s ability to diagnose and manage various forms of cancer and cardiovascular disease. NSI plans to take N1177 through proof of concept clinical studies and then sell it to a strategic partner to complete its development and commercialization. |
| Nanoselect, Inc. 15 Innovation Way (DBI) Newark , DE 19711 302-355-5987 Sal Pace pace@nanselect-sensors.com www.nanoselect.com NanoSelect is a nanotechnology company focused on the development of Carbon Nanotubes technology for specialty materials and bio-sensing applications in the Biotechnology and Medical Diagnostics industry. The company comprises a talented group of chemists, physicists and engineers dedicated to the development of MEMS and NEMS technologies in the field of life sciences. |
| NanoVec, Inc. 3701 Market Street Philadelphia, PA 19104 215-966-6000 Dr. Chad Womack cwomack@nanovec.com www.nanovec.com NanoVec, Inc. is an early stage biotechnology company developing next generation nanobiomolecular vaccines and therapeutics against infectious diseases, cancer and biothreats. |
| Neose Technologies, Inc. 102 Rock Road Horsham, PA 19044 215-315-9403 Kathryn Gregory, VP, Bus. Dev. kgregopry@neose.com www.neose.com Neose’s proprietary GlycoPEGylation technology improves the pharmacokinetic and pharmacodynamic properties of protein drugs. Candidates in development include GlycoPEG-GCSF (in collaboration with BioGeneriX AG), a phase-I completed product, for neutropenia associated with myelosuppressive chemotherapy; and GlycoPEG-FVIIa (under a license to Novo Nordisk) for the treatment of bleeding episodes and prevention of bleeding during surgery or invasive procedures in patients with congenital hemophilia with inhibitors to coagulation factors. |
| Neuronyx, Inc. 1 Great Valley Parkway Suite 20 Malvern, PA 19355 610-240-4150 Mary K. Luke info@neuronyx.com www.neuronyx.com Neuronyx is developing an allogeneic human adult bone marrow-derived somatic cell product (NX-CP105) for certain diseases resulting from ischemic injury such as myocardial infarction, stroke and dermal wounds. |
| NexusPharma Inc. 253-13 Summit Square Center Langhorne, PA 19047 732-274-0010 Lutz Weber info@nexuspharm.com www.nexuspharm.com NexusPharma is developing novel drug candidates to advance cancer treatment through non-cytotoxic mechanism-based approaches. The small molecule candidates target selected cancer-promoting protein-protein interactions and inhibit critical cancer signaling networks. NexusPharma leverages its new technologies for the design and development of small molecule protein-protein interaction inhibitors with the unique know-how, cell and systems biology expertise, and insight into the complex networks of cancer-related protein interactions of the Fox Chase Cancer Center. |
| Nitric BioTherapeutics, Inc. 2 Canal's End Road Suite 201-A Bristol, PA 19007 866-957-6200 NA info@nitricbio.com www.nitricbio.com NitricBio was created to develop and commercialize medical applications of topical nitric oxide gas. Nitric oxide has both direct and regulatory actions with known anti-infective and anti-inflammatory properties. Among the company's first initiatives is the treatment of chronic wounds, a major health care issue. |
| Novasep Process 23 Creek Circle Boothwyn, PA 19061 610-494-0447 Rache Deluca rachel.deluca@novasep.com www.novasep.com Novasep Process is leader in delivering innovative purification solutions for life sciences applications. Novasep Process solves purification challenges for the Pharmaceutical, Biopharmaceutical and Industrial Biotech markets. Novasep Process is part of the Groupe Novasep who is a technology-oriented company offering a large portfolio of innovative and cost effective syntheses and processes to produce molecules. |
| Novavax, Inc. 508 Lapp Road Malvern, PA 19355 484-913-1204 Robert Lee RLee@Novavax.com www.Novavax.com Novavax, Inc. is committed to leading the global fight against infectious disease by creating novel, highly potent vaccines that are safer and more effective than current preventive options. In addition, Novavax has pharmaceutical development capabilities which include micellar nanoparticle (MNP) technology, an enabling drug delivery platform. MNP technology is the basis for the development of its first FDA-approved product, Estrasorb®. |
| Novo Nordisk, Inc. 100 College Road West Princeton, NJ 08540 609-987-5800 Stephen McGill stnc@nvonrdsk.com www.novonordisk-us.com Novo Nordisk is the world's leading diabetes care company and the only company that provides a complete portfolio of insulin analog treatments and insulin delivery devices that respond to each stage of the diabetes life cycle. In addition, Novo Nordisk has a leading position in hemostasis management, growth hormone therapy and hormone therapy for women. |
| Nucleonics, Inc. 702 Electronic Drive Horsham, PA 19044 267-518-0100 Barbara Guido bguido@nucleonicsinc.com www.nucleonicsinc.com Nucleonics is developing novel therapeutics for infectious diseases, cancer and inflammatory conditions based on proprietary gene silencing technology known as expressed RNA interference. |
| Open Biosystems, Inc. 34 Sebastian Drive Newark, DE 19711 302-650-0100 Bill Morrison info@openbiosystems.com www.openbiosystems.com Open Biosystems offers products that span Genomics, RNAi and Antibodies. We offer several full-length cDNA and ORF collections, including the Mammalian Gene Collection (MGC). Our collaborations with Cold Spring Harbor Laboratory, MIT and Harvard have led the way in shRNA libraries. Open Biosystems is also the premier provider of antigen and antibody services, based on unique Antigen Profiler design software. |
| Orthovita, Inc. 77 Great Valley Parkway Malvern, PA 19355 610-640-1775 Antony Koblish, President & CEO akoblish@orthovita.com www.orthovita.com Orthovita is a spine and orthopedic biosurgery company with proprietary biomaterials and biologic technologies for the development and commercialization of synthetic, biologically active, tissue engineering products. Orthovita develops and markets synthetic-based biomaterials products for use in spine surgery, the repair of fractures and a broad range of clinical needs in the trauma, joint reconstruction, revision and extremities markets. |
| Othera Pharamceuticals, Inc. 730 Springdale Drive Exton, PA 19341 484-879-2800 Tina Paquin paquin@othera.com www.othera.com We are a specialty pharmaceutical company, focused on the design, development and commercialization of proprietary small molecule drugs for ophthalmic and other high-value indications based on a novel mechanism of action. Our primary interest in ophthalmics is to develop novel topical eye drop products that target age-related indications representing some of the biggest unmet needs in ophthalmology. |
| PBL InterferonSource 131 Ethe Rd West Suite 6 Piscataway, NJ 08854 173-277-79123 Jaleel Shujath info@interferonsource.com www.interferonsource.com PBL InterferonSource, a division of Pestka Biomedical Laboratories, is the world’s largest distributor of interferons and related products to the life sciences research market. Founded in 1990 by Dr. Sidney Pestka, PBL aims to provide the biomedical researcher with high quality interferon products and facilitate the advancement of research. |
| Polysciences Inc. 400 Valley Road Warrington, PA 18976 215-343-6484 Robert Gleim-VP New Business Development info@polysciences.com www.polysciences.com Polysciences Inc. is a privately held specialty chemical company that offers a range of product service including custom synthesis, contract manufacturing and packaging of biomedical products and intermediates. |
| Progenra, Inc. Great Valley Corpoprate Center 271A Great Valley Parkway Malvern, PA 19355 610-644-6974 Michael R Mattern mattern@progenra.com www.progenra.com Progenra Inc. is a biotechnology company committed to drug discovery utilizing the ubiquitin and ubiquitin-like protein pathways. Through its platform for high-throughput screening against novel drug targets in these pathways, Progenra’s goal is to develop medicines to treat cancer, muscle wasting, Parkinson’s, and other diseases. Progenra is currently expanding its discovery platform to include every viable target in these pathways. |
| Promedior, Inc. 5 Great Valley Parkway Suite 300 Malvern, PA 19355 610-560-1435 Timothy J. Pelura, Ph.D. tpelura@promedior.com www.promedior.com Promedior, Inc. is a product-focused biopharmaceutical company developing novel therapeutics for the treatment of fibrotic disorders and diseases. Promedior has license to novel biology and is developing innovative new compounds and therapies based on that biology. With leadership and advisors on the cutting edge of fibrosis research, Promedior is positioned to be a leader in the development of new therapies for fibrotic disorders and diseases. |
| Protalex, Inc. 145 Union Square Drive New Hope, PA 18938 215-862-9720 Marc L. Rose information@protalex.com www.protalex.com Protalex, Inc. is a biotechnology company developing a novel, new class of drugs for the treatment of various autoimmune disorders. |
| PuriCore, Inc. 508 Lapp Road Malvern, PA 19355 484-321-2700 Kelli Johnson kjohnson@puricore.com www.puricore.com A life sciences company developing and commercializing technology that mimics the human body’s production of its natural anti-microbial, hypochlorous acid. Hypochlorous acid is highly effective at killing pathogens, yet is safe and environmentally friendly. |
| Redpoint Bio Corporation 2005 Eastpark Blvd. Cranbury, NJ 08512 609-860-1500 Ray Salemme bhoover@redpointbio.com www.redpointbio.com Redpoint Bio is a development-stage biotech company using advanced technology to discover and develop novel taste enhancers and aversive taste blockers for the pharmaceutical, food and beverage industries. We are developing more palatable formulations of medicines that offer improved acceptability and compliance, or allow novel routes of administration through absorption in the mouth. |
| Renaissance Scientific, LLC 309 Parklawn Court Lancaster, PA 17601 717-575-0115 Sandra Urdaneta Hartmann, M.D., Ph.D. rensci@hotmail.com Scientists of our early-stage company discovered and patented the novel use of sodium dodecyl sulfate (SDS) as the active ingredient in personal care products (e.g., gels/lubricants, condoms) for prevention of sexual transmission of human immunodeficiency virus type 1 (HIV-1), herpes simplex virus type 2 (HSV-2) and human papillomaviruses (HPV). Other novel broad-spectrum microbicidal applications of SDS are in the pipeline. |
| Rockland Immunochemicals, Inc. P.O. Box 326 Gilbertsville, PA 19525 800-656-7625 Tabitha A. Patrick sales@rockland-inc.com www.rockland-inc.com Rockland Immunochemicals is a global biotechnology company manufacturing leading-edge research tools and cGMP grade proteins for basic, applied and clinical research in functional genomics, gene therapy and drug discovery markets. Rockland operates outside of Philadelphia, Pennsylvania, USA. European and Asian markets are supported through a highly specialized network of key distributors. |
| Russell Biotech, Inc. 634 Meadwobrook Drive Huntingdon Valley, PA 19006 215-914-1276 Thomas Russell trussell@russellbiotech.com www.russellbiotech.com Russell Biotech provides innovative solutions for biological separations based on proprietary technology. Applications include separation of cells, proteins and nucleic acids. Products are being developed for research, diagnostic and therapeutic markets. |
| Secant Pharma 907 Edgewood Lane Langhorne, PA 19053 215-741-1165 Dale M. Lombardi dlombardi@secantpharma.com www.secantpharma.com Secant Pharma is a U.S.-based privately held specialty pharmaceutical company that operates internationally and is devoted to the development and commercialization of innovative, differentiated, value-generating therapeutics for market segments with unmet medical needs. The primary focus of the company at this time is to fully capitalize on the intellectual property that it owns. |
| Sepax Technologies, Inc. Delaware Technology Park 5-100 Innovation Way Newark, DE 19711 302-366-1101 Chris Huang, Ph.D. info@sepax-tech.com www.sepax-tech.com Sepax Technologies, Inc. develops and manufactures products in the area of chemical and biological separations, biosurfaces and proteomics. The Sepax product portfolio includes a wide range of high resolution, high efficiency liquid chromatography instruments, columns, resins, and novel capillary coatings for DNA sequencing and protein separation. |
| Simmons Consulting 19 Stirrup Run Newark, DE 19711 302-379-1876 Kirk Simmons SimmonsConsulting@gmail.com http://www.linkedin.com/in/kirksimmons Simmons Consulting provides consulting services in the area of cheminformatics, screening library design, design of experiments (DOE), predictive modeling and analysis of high-throughput experimental results. Extensive experience in organic chemistry, lead optimization strategies, and physical property predictions of small organics (logS, logVp and pKa). |
| Skanska USA Building, Inc. 516 East Township Line Road Suite 100 Blue Bell, PA 19422 267-470-1000 Ron Jones ron.jones@skanskausa.com www.skanskausa.com Skanska is a leader in providing construction services to clients in the pharmaceutical and biotechnology manufacturing/process industries. We have the capabilities to construct, renovate and expand facilities from 1,000 square feet to more than 300,000 square feet. We also specialize in handling projects in Puerto Rico for many of our clients, with whom we’ve developed long-term relationships – making us a leader in repeat business. |
| Soligenix, Inc. 29 Emmons Drive Suite C-10 Princeton, New Jersey 08650 609-538-8200 Annu Mangat info@soligenix.com www.soligenix.com Soligenix, Inc. is a late-stage biopharmaceutical company developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines for certain bioterrorism agents. Soligenix's lead product, orBec® (oral beclomethasone dipropionate or BDP), is a potent, locally acting corticosteroid being developed for the treatment of acute gastrointestinal Graft-versus-Host disease (GI GVHD), a common and potentially life-threatening complication of allogeneic hematopoietic cell transplantation. |
| Sopherion Therapeutics 104 Carnegie Center Suite 200 Princeton, NJ 08540 609-986-2021 NA info@sopherion.com www.sopherion.com Sopherion Therapeutics, Inc. is a privately held biopharmaceutical company headquartered in Princeton, New Jersey and maintains preclinical R&D in New Haven, Connecticut and an operating subsidiary, Sopherion Therapeutics Canada, in Toronto, Canada. The Company is focused on developing oncology and oncology-related therapies and is leveraging its Minicell Peptide Display™ screening technologies to identify additional therapies for cancer and related areas. |
| SSPCC, Inc. 21 Pin Oaks Drive Suite 101 Phoenixville, PA 19460 610-933-9689 Caroline Bell cpbell@sspcc.com sspcc.com Consultant, Preclinical Development and IND Strategy. 25+ years pharmaceutical R&D. Toxicology and Safety Pharmacology - CRO Management (protocol, in-life, report, regulatory summary documents), facility audit, design/implementation of in-house capability. Risk/safety profiles assessment, IND/NDA submissions. State-of-the-art Safety Pharmacology technologies, GLP, Investigative studies Phase II-IV, preclinical toxicological issues, regulatory reports, executive operations management. Board of Directors Safety Pharmacology Society. Full resume www.sspcc.com |
| Stan Bumble, PH.D. 8922 Krewstown Rd., 112 Philadelphia, PA 19115 215-671-0409 Stan Bumble, Ph. D. stan2@excite.com Synthetic Biology, Systems Biology, New Energy Sources, Metabolic Engineering, Genetic, Protein and Metabolic Networks, Alternate Biochemical Pathways for Microbial Synthesis, Robust Self-Assembly, Evolution of Biological Networks, Biological Process Network Synthesis and Analysis, Chaos Theory, Critical Areas Between Chaos and Order, Emergence and Expression in Biological Systems, Improved Databases for the Combinatorial Computer Generation of Candidate Drug Molecules and Their Discovery, Program Design for Smarter Lead Discovery. |
| Strategic Diagnostics, Inc. 111 Pencader Drive Newark, DE 19702 302-456-6789 David Schlecker dschlecker@sdix.com www.sdix.com Strategic Diagnostics Inc., headquartered in Newark, DE, is a biotechnology company dedicated to bringing innovative solutions to the production of custom and catalogue antibodies as well analytical testing problems. SDI is a leading developer of test kits for waste site assessment, water quality, food pathogens and transgenic crop seed production. SDI pioneered the production of Antibodies by developing Genomic Antibodies. |
| Tengion, Inc. 2900 Potshop Lane Suite 100 East Norriton, PA 19403 610-292-8364 Gary Sender, CFO info@tengion.com www.tengion.com Tengion, a clinical stage company founded in 2003, is developing new human tissues and organs derived from a patient's own cells. Tengion's patented technology harnesses the body's ability to regenerate, which has the potential to allow adults and children with organ failure to have functioning organs built from their own tissues. This would enable them to lead healthier lives without the need for donor transplants. |
| The Business/Technology Interface, LLC 21 Tenby Chase Voorhees, NJ 08043 856-753-7650 Richard S. Woodward rswoodward@net-gate.com The Business/Technology Interface, LLC provides business strategy, business development and technical operations support to early-stage companies in the pharma, biotech and specialty chemicals fields. These services have been characterized as a "COO for hire." |
| Topaz Pharmaceuticals LLC 130 Greenwwod Ave. Jenkintown, PA 19046 215 990 5145 Nick Spring nick_spring@topazpharma.com www.topazpharma.com The mission of Topaz Pharmaceuticals LLC is to provide the field of pediatrics with innovative products that will facilitate the treatment of common pediatric diseases and conditions, especially those that occur in children from 0 -13 years of age. The initial focus of Topaz Pharmaceuticals LLC will be on head lice control products. |
| Toxikon 1255 Marigold Street North Brunswick, NJ 08902 716-566-8181 Charudutt Shah charudutt.shah@toxikon.com www.toxikon.com Toxikon is an industry leading global contract research organization that has been serving the life science community for over 30 years. Our facilities in US and Europe provide FDA/ICH/OECD safety testing services for the medical device and biotechnology industries. We specialize in biocompatibility studies, sterilization, microbiology, extractables and leachable studies, PK/TK, ADME, in-vivo toxicology, IND enabling studies and bio-analytical services with GxP standards. |
| Vector BioLabs 3701 MARKET ST, Ste 434 Philadelphia, PA 19104 215-966-6045 Ken Guo, PhD info@vectorbiolabs.com www.vectorbiolabs.com Vector Biolabs is a biotechnology company focusing on the development of gene delivery technology for the life science research community. |
| VWR International 1310 Goshen Parkway West Chester, PA 19380 610-431-1700 Erika Broadwater erika_broadwater@vwr.com www.vwrjobs.com VWR International is a leader in the global research laboratory industry with worldwide sales in excess of $3 billion US dollars. VWR's business is highly diversified across products and services, geographic regions and customer segments. The company offers products from a wide range of manufacturers, to a large number of customers primarily in North America, Europe and other locations. |
| Wyeth Pharmaceuticals 500 Arcola Rd. Collegeville, PA 19426 484-865-5000 Patrick Plues pluesp@wyeth.com www.wyeth.com Wyeth is a global leader in prescription pharmaceuticals, non-prescription consumer health products, and pharmaceuticals for animal health. Wyeth's product portfolio includes innovative treatments across a range of therapeutic areas. Wyeth's resources include 50,000 employees, manufacturing facilities on four continents, and a technology base encompassing small molecules, biopharmaceuticals, genetic engineering that will provide the next wave of innovative therapies and vaccines. |
| Yaupon Therapeutics, Inc. 259 Radnor Chester Road Suite 210 Radnor, PA 19087 610-975-9290 Robert Alonso robert@yaupontherapeutics.com www.yaupontherapeutics.com Yaupon Therapeutics is a privately held specialty pharmaceutical company that develops small molecule pharmaceuticals licensed from under-served academic laboratories using an intensely capital-efficient business model. The company has four products in development, with one compound in pivotal studies, one compound in phase 2 and additional compounds that will enter the clinic in 2007. |